|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|
| Net sales | |
| Cost of products sold | |
| Impairment of long-lived assets | |
| Gross profit (loss) | |
| Operating expenses: | |
| Research and development | |
| Selling, general and administrative | |
| Total operating expenses | |
| Loss from operations | |
| Other income (expense), net: | |
| Grant income | |
| Interest expense | |
| Interest income | |
| Remeasurement of derivative liabilities and convertible notes | |
| Total other income (expense), net | |
| Loss before provision for income taxes | |
| Provision for income taxes | |
| Net loss | |
| Net loss per share of common stock, basic and diluted | |
| Weighted-average number of shares used in net loss per share of common stock, basic and diluted |
Loading...
